SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-098160
Filing Date
2010-10-29
Accepted
2010-10-29 16:12:26
Documents
4
Period of Report
2010-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c07441e8vk.htm 8-K 23220
2 EXHIBIT 10.1 c07441exv10w1.htm EX-10.1 21013
3 EXHIBIT 10.2 c07441exv10w2.htm EX-10.2 22141
4 EXHIBIT 99.1 c07441exv99w1.htm EX-99.1 8706
  Complete submission text file 0000950123-10-098160.txt   77072
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS BIOTECHNOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17263 | Film No.: 101152040
SIC: 2836 Biological Products, (No Diagnostic Substances)